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Abstract
Background. It is well documented that infective
endocarditis (IE) is strongly associated with morbidity
and mortality in haemodialysis (HD) patients. Less
clear are the mortality risk factors for IE, particularly
in an urban African-American dialysis population.
Methods. IE patients were identified from the medical
records for the period from January 1999 to February
2004 and confirmed by Duke criteria. The patients
were classified as ‘survivors’ and ‘non-survivors’
depending on in-hospital mortality, and risk factors
for IE mortality were determined by comparing the
two cohorts. Survivors were followed as out-patients
with death as the endpoint.
Results. A total of 52 patients with 54 episodes of
IE were identified. A catheter was the HD access in
40 patients (74%). Mitral valve (50%) was the commonest valve involved, and Gram-positive infections
accounted for 87% of IE. In-hospital mortality
was high (37%) and valve replacement was required
for 13 IE episodes (24%). On logistic regression
analyses, mitral valve disease [P ¼ 0.002; odds
ratio (OR) ¼ 15.04; 95% confidence interval
(CI) ¼ 2.70–83.61] and septic embolism (P ¼ 0.0099;
OR ¼ 9.56; 95% CI ¼ 1.72–53.21) were significantly
associated with in-hospital mortality. Using the Cox
proportional hazards model, mitral valve involvement
(P ¼ 0.0008; hazard ratio 4.05; 95% CI ¼ 1.78–9.21)
and IE related to drug-resistant organisms such
as methicillin-resistant Staphyloccus aureus and
vancomycin-resistant Enterococcus sp. (P ¼ 0.016;
hazard ratio 2.43; 95% CI ¼ 1.18–5.00) were associated
with poor outcome after hospital discharge.
Conclusions. IE was associated with high mortality
in our predominantly African-American dialysis
population, when the mitral valve was involved,
Correspondence and offprint requests to: Uday S. Nori, MD,
Division of Nephrology, N210 Means Hall, 1654 Upham Drive,
Columbus, OH 43210, USA. Email: unori12002@yahoo.com

or septic emboli occurred and if MRSA or VRE were
the causal organisms.
Keywords: catheters; endocarditis; end-stage
renal disease; mortality; septic emboli

Introduction
While Sir William Osler is credited for his initial
clinical description of infective endocarditis (IE), Blagg
and his associates [1] were the first to report this
complication in haemodialysis (HD) patients. Infection
is a significant contributor to mortality in dialysis
patients, next only to cardiovascular disease [2], and
specifically, IE can be a catastrophic complication.
Among the high-risk groups for IE (i.e. intravenous
drug users, native/prosthetic valve disease etc.), HD
patients deserve special mention. The incidence of IE is
at least 10–18 times higher in dialysis patients than in
the general population [3] and is associated with higher
in-hospital and 1-year mortality [4–6]. In addition, IE
leads to lengthy and expensive hospitalizations [4,5,7].
HD catheters contribute significantly to the increasing
incidence of bacteraemia [8] and as a result, to IE. Even
though the National Kidney Foundation’s Kidney
Disease Outcomes Quality Initiative (K/DOQI)
clinical practice guidelines clearly recommend native
arteriovenous fistula (AVF) as the preferred vascular
access [9], a substantial proportion (28%) of chronic
dialysis patients continue to use a catheter as a
permanent HD access [10].
Prior studies have described the epidemiology of IE
and risk factors for mortality [3–7,11] in a predominantly non-African-American dialysis population
and had focused on mortality during hospitalization
related to IE. In this retrospective study, we sought
to identify risk factors for mortality in our large,
urban dialysis population that is composed predominantly of patients of African-American ethnicity.
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In addition, we extended our observation to overall
survival of these subjects with post-hospitalization
follow-up.

Materials and methods

All end-stage renal disease (ESRD) patients discharged from
the Henry Ford Hospital, Detroit, with a diagnosis of IE,
between January 1999 and February 2004, were identified
from the electronic databases using International
Classification of Disease-9 (ICD-9) codes for ESRD (585.0)
and IE (421.0, 421.1 and 421.9). The average number of
patients undergoing chronic HD is approximately 1000 per
year, about 90% of these patients are of African-American
ethnicity. This study was approved by the local institutional
review board.

Data collection
Demographic, clinical, echocardiographical and microbiological information was obtained from the patient’s chart or
the institution’s computerized medical records (CareplusÕ ).
Collected data included age, gender, ethnic origin, history
of diabetes mellitus (DM), hypertension, intravenous drug
abuse (IVDA), hepatitis B and hepatitis C serologies, serum
albumin, type of HD access, and the time interval from the
placement of access to the diagnosis of IE. Microbiological
data comprised the type of organism isolated from
blood and the catheter tip. Transthoracic (TTE) and
transesophageal (TEE) echocardiogram reports, type of
valve involved and cardiac complications of IE were reviewed
for the diagnosis.
To identify the risk factors associated with mortality
during hospitalization, the identified subjects were divided
into two groups depending on survival during the
hospitalization (non-survivors in group A and survivors in
group B) and patient characteristics were compared. The
cohort of patients who survived the hospitalization was
followed for a period of 1–59 months with death as the
endpoint. Follow-up data was obtained from the computerized records of out-patient, in-patient visits and dialysis
rounds.

Definitions
Modified Duke criteria were used to define IE and only the
definite IE cases were included i.e. if the patient had two
major criteria or one major and three minor criteria or five
minor criteria [12]. Access that was utilized for HD just prior
to hospitalization was defined as the vascular access for
dialysis. Duration of access was defined as the time interval
between the placement of that access and the time of
hospitalization. All surgeries done on cardiac valves during
that index hospitalization were defined as valve surgery.
Septic embolization was determined according to the clinical
evaluation documented in the charts and confirmed by
radiological tests in some cases.

Statistical analyses
The demographic and clinical data are presented as the
proportion of patients in each group or as the mean 
standard deviation. Fisher’s exact test or two-tailed
Student’s t-test were used for statistical analysis as appropriate. A P-value of <0.05 was considered statistically
significant.
The patient characteristics that individually showed
statistically significant association with mortality during
hospitalization were the only variables included in the final
multivariate analyses. Stepwise logistic regression analysis,
using the SAS logistic procedure, was applied. Outcomes
of the analysis included P-values, odds ratios (ORs) and
hazard ratios and their 95% confidence limits. To assess
the impact of IE on overall survival, Cox proportional
hazard regression analysis was performed on the entire
cohort of patients. Survival curves were calculated by
Kaplan–Meier method and the curves were compared by
the log-rank test.

Results
Using the Duke criteria, 54 episodes of definite
IE were identified in 52 ESRD subjects during the
5-year study period. The average number of patients
who underwent maintenance HD at our institution
during the study period was 1000 patients/year,
translating to an incidence of 11 cases per 1000
patient-years. The patient’s clinical and demographic
data are shown in Table 1. While gender distribution
was equal, African-Americans accounted for the
majority of cases of IE (85%). Even though the mean
age was 60 years (range 36–82), a significant proportion (27%) of patients were 70 years of age. History
of DM and IVDA was present in 42 and 12% of
patients, respectively. A history of prior IE was noted
in only 12% patients.
In our series, 40 patients (74%) had a catheter as the
HD vascular access at the time of diagnosis of IE,
while the other patients had prosthetic arteriovenous
grafts (13%), subcutaneously implanted dialysis
access ports (Life-SiteÕ ) (9%) or native arteriovenous
fistulae (4%). Among the catheter patients, the
majority (72%) had cuffed, tunnelled catheters. The
mean duration (SD) of the cuffed, tunnelled catheter
was 24  26 weeks.
While a TTE study was able to identify vegetations
in 13% of patients, the majority of patients (87%)
had TEE to confirm the diagnosis. In our series,
mitral valve (50%) was the commonest valve involved
(Table 2), followed by aortic (43%) and tricuspid
valve (19%). Staphylococcus aureus (40%) and
Enterococcus (33%) were the most common microbiological pathogens.
Nineteen patients (37%) died during the hospitalization for IE and 13 more patients died during the
follow-up period. Among the survivors, the mean
(SD) duration of hospital stay was 18  11 days.
Septic emboli related to IE were noted in 15 patients
(28%) and two-thirds of those patients (n ¼ 10) died
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Table 1. Characteristics of ESRD patients admitted with IE

Table 3. Comparison between survivors and non-survivors of
IE-related hospitalization

n (%)
52
54
60  12
1 (2%)
13 (25%)
13 (25%)
11 (21%)
14 (27%)
48%/52%
44 (85%)
8 (15%)
22 (42%)
41 (79%)
6 (12%)
6 (12%)
12 (23%)
2 (4%)
2.9  0.6
1 (2%)
39 (72%)
7 (13%)
2 (4%)
5 (9%)
24  26
47 (87%)
7 (13%)

a

Entries are represented as mean  SD.
Percentage in parenthesis was calculated as proportion of IE
episodes.
c
Implantable subcutaneous haemodialysis port.

Male gender
Age (years)a
Age 65 years
African-Americans
History of DM
IV Drug use
Serum albumina
Access: Catheters
Life siteÕ
AVG
AVF
Duration of cuffed
catheter (weeks)a
Echocardiogram
Mitral valve
Aortic valve
Tricuspid valve
Multi-valvular inv
LV ejection fraction
Microbiology
MRSA
MSSA
Polymicrobial
Drug-resistant org
[MRSA þ VRE]
Outcome
Septic embolism
Septic emboli to Brain
Valve replacement

Group A
Non-survivors
(n ¼ 19)

Group B
Survivors
(n ¼ 33)

P-value

11 (58%)
61  12
7 (37%)
17 (89%)
6 (32%)
1 (5%)
2.6  0.43
14 (74%)
2 (11%)
1 (5%)
2 (11%)
19  13

17 (51%)
59  12
12 (36%)
31 (94%)
17 (51%)
5 (15%)
3  0.6
26 (79%)
3 (9%)
6 (18%)
0 (0%)
26  30

NS
NS
NS
NS
NS
NS
<0.007
NS
NS
NS
NS
NS

16 (84%)
6 (32%)
1 (5%)
3 (16%)
58  5%

11 (31%)
17 (49%)
9 (23%)
2 (6%)
50  15%

0.0004
NS
NS
NS
<0.007

6
5
5
8

5
6
5
7

NS
NS
NS
NS

(32%)
(26%)
(26%)
(42%)

10 (53%)
6 (32%)
5 (26%)

(14%)
(17%)
(14%)
(20%)

5 (14%)
1 (3%)
8 (23%)

0.004
<0.006
NS

b

Table 2. Valve involvement and the type of organism associated with
infective endocarditis in haemodialysis patients
n (%)
Echocardiogram
Valve involvement
Mitral valve
Aortic valve
Tricuspid valve
Multiple valve
Microbiology
MSSAa
MRSAb
Enterococcus
VREc
S. epidermis
Resistant org [MRSA þ VRE]
Gram negative organisms
Negative blood culture
Polymicrobial

27 (50)
23 (43)
10 (19)
5 (9)
11 (20)
11 (20)
18 (33)
4 (7)
12 (22)
15 (28)
7 (13)
1 (2)
10 (19)

a

MSSA: methicillin-sensitive S. aureus.
MRSA: methicillin-resistant S. aureus.
c
VRE: vancomycin-resistant Enterococcus sp.
b

during hospitalization. The sites of septic embolism,
in descending order of frequency, were as follows:
brain (n ¼ 7), joints (n ¼ 4), extremities (n ¼ 3), spleen
(n ¼ 2), kidneys, liver and lung (n ¼ 1).

a

Mean  SD.

Death during hospitalization
The clinical and laboratory characteristics were compared between the patients who died during the
hospitalization for IE (group A) and the patients
who survived that admission (group B). As explained
in Table 3, the clinical characteristics such as gender,
age 65 years, ethnicity, history of diabetes, hypertension or IVDA and the type of dialysis access did not
differ significantly between the groups. Similarly, the
time interval between the placement of the tunnelled
catheter and the diagnosis of IE was not statistically
different between the groups (group A: 19  13 weeks
vs group B: 26  30 weeks, P ¼ 0.31). Serum albumin
was lower in group A (2.6  0.43 g/dl) compared with
group B (3  0.6 g/dl) and the difference was statistically significant (P < 0.007) on univariate analysis.
While aortic valve involvement was not associated with
an increased risk of death, mitral valve disease was
significantly associated with mortality (84 vs 31%,
P ¼ 0.0004). Interestingly, survivors of the hospitalization had a lower left ventricular ejection fraction
(LVEF) compared with non-survivors (50  15% vs
58  5%, P ¼ 0.007). Overall, the type of microorganism was not statistically different between the two
groups. Specifically, IE related to drug-resistant
organisms like methicillin-resistant S. aureus (MRSA)
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Number of patients (n)
Number of IE episodes
Age (years)a
Age
30–39
40–49
50–59
60–69
70 years
Gender (female/male)
Ethnicity
African-American
Caucasian
History of diabetes mellitus
History of hypertension
History of intravenous drug use
Prior history of IE
Hepatitis C antibody (þ)
Hepatitis B surface antigen (þ)
Serum albumin (gm/dl)a
Dialysis accessb
Uncuffed catheter
Cuffed tunnelled catheter
Arteriovenous grafts (AVG)
Arteriovenous fistula (AVF)
Life-SiteÕ c
Duration of cuffed catheter (weeks)a
Valveb
Native valve
Prosthetic valve
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Follow-up after hospital discharge
Group B patients (survivors, n ¼ 33) were followed
after hospital discharge and 13 more patients died
during follow-up. Using the Cox proportional-hazards

model, risk factors for overall mortality were analysed.
Mitral valve involvement (P ¼ 0.0008; hazard ratio
4.05; 95% CI 1.78–9.21) and IE related to MRSA and
VRE (P ¼ 0.016; hazard ratio 2.43; 95% CI 1.18–5.00)
were significantly associated with poor outcome
(Table 4). The negative influence of these two variables
on patient survival after hospitalization is illustrated
in Figures 1 and 2.
Valve surgery
Valve damage, resulting from IE, necessitated valve
replacement surgery in 12 patients for 13 IE episodes
(24%). In spite of surgical intervention, five patients
died during hospitalization. Left ventricular ejection
fraction was identical between the patients who
underwent surgery and the patients on medical
management (LVEF: 55  13 vs 53  3%, P ¼ 0.58).
As illustrated in Figure 3, the subgroup of patients who
underwent surgical repair had similar survival compared with patients who received medical management
(P ¼ 0.97).

Table 4. Multivariate Cox proportional-hazards model for risk factors associated with post-hospitalization mortality in IE

Mitral valve involvement
IE related to MRSAa and VREb
a

Estimate

SE

Chi Square

P-value

Hazard ratio (95% CI)

1.40
0.89

0.419
0.368

11.15
5.83

0.0008
0.016

4.05 (1.78–9.21)
2.43 (1.18–5.00)

MRSA: Methicillin-resistant S. aureus.
VRE: Vancomycin-resistant Enterococcus sp.

b

Fig. 1. Patients with mitral valve IE had inferior patient survival when compared with the patients with other valve involvement.
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and vancomycin-resistant Enterococcus sp. (VRE) did
not result in excess to in-hospital mortality (42 vs 20%,
P ¼ 0.11). Septic embolus to the brain was significantly
associated with an increased risk of death (32 vs 3%,
P < 0.006).
The three patient characteristics (serum albumin,
mitral valve disease and septic embolism) in Table 3
that individually showed statistically significant association with survival or non-survival during hospitalization were tested for their joint association using
stepwise logistic regression. Only two of the characteristics, mitral valve disease [P ¼ 0.002; OR ¼ 15.04; 95%
confidence interval (CI) ¼ 2.70–83.61] and septic embolism (P ¼ 0.0099; OR ¼ 9.56; 95% CI ¼ 1.72–53.21),
were significantly associated with non-survival during
that hospitalization.
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Discussion

regurgitation and this could have contributed to the
erroneous observation of high LVEF.
Septic embolism, specifically embolus to the brain
and resulting stroke, was also significantly associated
with death, but that effect was confined to in-hospital
mortality. However, if the patient survived that
hospitalization, embolic episode did not negatively
influence survival after hospital discharge.
S. aureus was the most common pathogen in our
series and previous studies have reported similar
findings [4–7,13,14]. Contrary to earlier observations
[11], the type of organism, specifically IE related
to MRSA and VRE, did not influence in-hospital
mortality. However, we noted that these organisms
had an impact on overall patient survival and this was
consistent with the observation of Cabell et al. [15] in
their cohort of IE patients that included dialysis
and non-dialysis population.
It is known from earlier studies that hypoalbuminaemia predicts mortality risk in acute illnesses,
including bacteraemia, and has been a component of
various critical care unit outcome measures [16]. Serum
albumin levels may fall acutely with inflammation
(‘negative acute phase reactant’), acute or chronic
stress and increase following resolution or recovery.
However in our study, even though hypoalbuminaemia
was associated with higher mortality on univariate
analysis, it was not independently associated with
death on regression analyses. While hypoalbuminaemia has been associated with an increased risk of
bacteraemia [17] and IE [3], Chang et al. [11] had
reported findings similar to our series of lack of
association between hypoalbuminaemia and mortality

Fig. 2. IE related to drug-resistant organisms such as methicillin-resistant S. aureus (MRSA) and vancomycin-resistant Enterococcus (VRE)
resulted in poor patient survival.
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In this study, we report 54 episodes of IE in HD
patients, making this the largest reported series in this
population to the best of our knowledge. The unique
attributes of our study compared with the previous
publications are that the large majority of the study
population is from African-American ethnicity and
that we have identified important in-hospital mortality
risk factors in these patients. These observations have
not been reported in any of the previously published
studies. Our data also confirmed the high mortality
rate associated with IE, as noted in other studies.
Consistent with prior observations [4,6,7,13], leftsided valvular vegetations were more common in
our study population. In addition to being the most
commonly involved valve, mitral valve involvement
was strongly associated with in-hospital mortality
and impacted overall patient survival negatively. In
our study, a significantly higher proportion of nonsurvivors had mitral valve involvement compared with
survivors and many of these patients had evidence of
septic emboli, including the brain. We speculate that
the lower gradient across the mitral valve (as compared
with the aortic valve) might have allowed the lesions
to attain a larger size before shearing off, leading
to clinically significant septic emboli. Interestingly,
the non-survivor group had better left ventricular
function as compared with survivors at the time of
echocardiographic evaluation. This may be related to
the fact that non-survivors had a significantly higher
rate of mitral valve involvement and IE-related mitral
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in IE patients. A prospective study with larger
sample size is required to verify the negative influence
of hypoalbuminaemia on survival in HD patients
with IE.
Valve replacement surgery did not impact survival
in our patients. The American College of Cardiology/
American Heart Association task force has defined
indications for valvular surgery in patients with native
and prosthetic endocarditis [18]. However, the indications in patients with significant comorbid conditions
are less clear. Recently, Spies et al. [7] reported high
perioperative mortality in dialysis patients who underwent valve replacement surgery for endocarditis.
It is possible that this intervention may have been
employed at an advanced stage of the disease, when
serious embolic complications had already set in,
and patients selected for surgery may have had severe
disease.
The data presented in this study clearly underline
the importance of vascular catheters as the source of
bacteraemia and IE. Even the recent trend to use
cuffed, tunnelled HD catheters instead of the uncuffed
catheters has not translated to a significant reduction
in the catheter-related bacteraemia in HD patients [19].
Our study has some of the inherent limitations of
any retrospective chart review. First, echocardiographic data were only available in selected individuals
who may have been clinically ill, with the potential
for missing clinically silent disease in other patients.
Second, we could have missed data that were not
appropriately coded for IE and dialysis patients who
were admitted to other hospitals. Third, patients were
chosen for surgery or medical management based on

individual physician’s decision rather than pre-defined
study criteria. Hence the lack of efficacy of surgery
may just be an observation. The sample size was small
and type II (b) error may be high. The small sample
size could have also accounted for both the wide 95%
CIs and non-statistical significance between the groups
with regards to certain variables and outcomes.
Fourth, we could not include a control group of HD
patients with bacteraemia but without endocarditis,
since many such individuals did not undergo echocardiography. Finally, IE related to MRSA and VRE
were associated with poor prognosis during follow-up.
These organisms may be surrogate markers of multiple
hospitalizations and antibiotic therapies. Complete
data could not be obtained regarding individual
patient’s antibiotic use prior to hospitalization.
A larger sample needs to be studied prospectively to
individually characterize the risk factors and confirm
the efficacy of therapeutic options. Our study population was comprised predominantly of urban patients
of African-American ethnicity on HD. Hence the
mortality risk factors identified in our study may
not be applicable to all dialysis patients, including
peritoneal dialysis.
In summary, our study has identified mitral valve
involvement and clinically evident septic embolism as
definite risk factors for in-hospital mortality in HD
patients with IE, in addition to confirming the high
incidence and high in-patient mortality associated
with this disease. Similarly, mitral valve disease and
IE related to drug-resistant organisms are associated
with poor overall patient survival even after hospital
discharge.
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Fig. 3. Comparison of Kaplan–Meier survival curves for a HD patients who underwent valve replacement (surgery group) vs medical
management (non-surgery group) for infective endocarditis.
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